Stay updated with breaking news from Stephen Harrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sagimet announced positive topline data from its FASCINATE-2 Phase 2b clinical trial of denifanstat in MASH in January 2024 and plans to initiate Phase 3 trial in the second half of 2024SAN MATEO,...
Investegate announcements from Chairman Succession and Director Appointment
Epwin Group PLC on Wednesday maintained a positive outlook as it reported double-digit profit growth, and announced the appointment of a new chair as Andrew Eastgate is set to retire next month. The...
Epwin Group investors can expect bumper payouts in 2024 after full-year profit beat market forecasts this morning.
SCORES of nominations have already been received for the 2024 Greenock Telegraph Community Champion Awards but with the deadline of April 5 now…